Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.
Angela LamarcaMaxime RonotSalma MoallaJoakim CronaMarta OpalinskaCarlos López LópezDaniela Pezzutti Domigues ArmentanoPavan NajranLuciana CarvhaloRegis Otaviano Franca BezerraPhilip BorgNaik Vietti VioliHector Vidal TruebaLouis de MestierNiklaus ScaeferEric BaudinAnders SundinFrederico CostaMarianne PavelClarisse DromainPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
TGR has a role as a biomarker for monitoring response to therapy for early identification of treatment-induced changes and for early prediction of PFS and radiologic objective response.